An interventional study of Trapeziectomy and Sham in Thumb Osteoarthritis, sponsored by Tampere University Hospital. Recruiting at 4 sites in Finland. Open to participants aged 45 Years and older. Per ClinicalTrials.gov, last updated 2026-11-02.
Sponsored by Tampere University Hospital · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 37 studies in Osteoarthritis with a site in Finland — 5 open to participants now, 10 under way, none of them phase 3. Osteoarthritis · Finland.
Among the 37 studies in Osteoarthritis with a site in Finland, this one is the 12th largest by planned enrollment of the 25 interventional ones that give a count, is the only one that started in 2022, is one of 15 with no phase, and was the 34th registered.
2,978 studies on the registry are indexed under Osteoarthritis; 438 are open to participants now.
Browse Osteoarthritis studies →5 of the 37 studies in Osteoarthritis with a site in Finland are open now. Recruiting first, the newest first:
Turku University Hospital · Sites in Finland
Ages up to 80
University of Turku · Sites in Finland
Ages 18–74 · Healthy volunteers
Töölö Hospital · Sites in Finland
Ages 18–75
Zimmer Biomet · Sites in Finland, United States, Australia and 5 more countries
Ages 18+
A study can be open while its sites in Finland have not opened yet or have stopped. Only those recruiting at a site in Finland →
Of the 285 Osteoarthritis studies recruiting now, 158 (55%) set no upper age limit and 70 (25%) stop at 75 or younger; 22 take children under 18; 31 take healthy volunteers.
This study: 45 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
37 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 1 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 132 is above the median of 80 across 2,242 interventional studies indexed under Osteoarthritis.
Median enrollment 120 across the 25 interventional studies, 138 across the 12 observational. Of the 23 that completed or were terminated, 5 (22%) have results posted.
This tab as a report to print or save as PDF → With an account.
16 of 37 have an industry lead sponsor. The 10 most frequent:
Tampere University Hospital is the lead sponsor of 212 studies on the registry; 56 are open to participants now.
Tampere University Hospital has 2 studies filed under Osteoarthritis — fewer than ten, so there is no comparison to draw.
2 of the studies in Osteoarthritis with a site in Finland that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT03372278Zimmer BiometPMCF Study on the Safety and Performance of the Zimmer® Maxera™ Acetabular System in Total Hip Arthroplasty | 2027-01 |
| NCT02038140Zimmer BiometZimmer Trabecular Metal Total Ankle PMCF | 2027-09 |
Add all 2 to your calendar (.ics) → With an account.
Among the 37 studies in Osteoarthritis with a site in Finland, from their registry updates:
This tab as a report to print or save as PDF → With an account.
A multi-center randomized placebo-controlled clinical trial which determines the efficacy of trapeziectomy in patients with persistent painful osteoarthritis at the base of the thumb. The primary outcome is patient reported evaluation of pain and function of the wrist and hand at 6 months after the randomization to treatment group.
A multi-center randomized placebo-controlled clinical trial which determines the efficacy of trapeziectomy in patients with persistent painful osteoarthritis at the base of the thumb (CMC1). The primary outcome is Patient Rated Wrist and Hand Evaluation (PRWHE) at 6 months after the randomization to treatment group. Secondary measures include PRWHE at 3 months, 1 year, 2 years and 5 years, grip strength, and global assessment of change.
The criteria were revised on the registry on Nov 2, 2026. See what changed
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Trapeziectomy
Procedure: Trapeziectomy
Placebo surgery
Procedure: Sham
Non-randomized observational arm (trapeziectomy, not blinded)
Procedure: Trapeziectomy
Surgical excision of trapezium bone
Skin incision only
Patient rated wrist and hand evaluation (PRWHE)
PROM questionnaire: PRWHE is a valid wrist and hand-specific composite measure comprising pain and function.
Time frame: 6 months after randomization
Patient rated wrist and hand evaluation (PRWHE)
PROM questionnaire: PRWHE is a valid wrist and hand-specific composite measure comprising pain and function.
Time frame: At baseline, 3 months, and 1, 2, 5 years after randomization, 6 months after possible secondary trapeziectomy
Global improvement (PGI-C)
PROM, question (Likert scale)
Time frame: At 3 and 6 months, and 1, 2, and 5 years after randomization, 6 months after possible secondary trapeziectomy
Patient Acceptable Symptom State (PASS)
PROM, question (Likert scale)
Time frame: At 3 and 6 months, and 1, 2, and 5 years after randomization, 6 months after possible secondary trapeziectomy
Patient rated wrist and hand evaluation (PRWHE) - pain subscale
PROM questionnaire
Time frame: At baseline, 3 months, 6 months, and 1, 2, 5 years after randomization, 6 months after possible secondary trapeziectomy
Patient rated wrist and hand evaluation (PRWHE) - function subscale
PROM questionnaire
Time frame: At baseline, 3 months, 6 months, and 1, 2, 5 years after randomization, 6 months after possible secondary trapeziectomy
EuroQol EQ-5D-5L, index value
PROM, health-related quality of life questionnaire
Time frame: At baseline, 3 and 6 months, and 1, 2, and 5 years after randomization
EuroQol EQ-5D-5L, Visual Analogue Scale (VAS) (EQ VAS)
PROM, health-related quality of life questionnaire
Time frame: At baseline, 3 and 6 months, and 1, 2, and 5 years after randomization
Grip strength
Measured with dynamometer
Time frame: At baseline, 6 months after randomization
Pinch strength
Measured with dynamometer
Time frame: At baseline, 6 months after randomization
Pain medication
Frequency of pain medication for thumb pain in the past week (categorial, 4 step)
Time frame: At baseline, 3 months, 6 months, and 1, 2, 5 years after randomization
Harms
Harms and healthcare contacts related to the operated hand will be collected systematically and unprompted using a standardized electronic case report files (eCRF). Events will be classified by type (Adverse event, Serious Adverse Event, Suspected Unexpected Serious Adverse Reaction), attribution, timing, and nature.
Time frame: After intervention (intraoperative), at 3 months, 6 months, and 1, 2, 5 years after randomization and as unprompted participant contacts
Adherence to post operative rehabilitation
Patient rated proportion of adherence, 0-100%
Time frame: at 3 months after randomization
Unblinding
Number of unblinded participants per group
Time frame: at 3 months, 6 months, and 1, 2, 5 years after randomization
Cross-over
Number of unblinded participants per group
Time frame: at 3 months, 6 months, and 1, 2, 5 years after randomization
Plan to share: No — In this trial IPD sharing is restricted by data protection regulations
No publications or documents are linked to this record.
Started Jan 2022 (actual). Primary completion is estimated for Sep 2028, 80 months after the start.
Of 578 non-industry interventional studies with no phase under Osteoarthritis, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 51. This study's planned 80 months is above that.
Counting every sponsor, half of 713 studies reached it within 28 months; a quarter within 11 and three quarters within 57.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 2, 2026: primary completion Dec 2024 → Sep 2028 and completion Dec 2029 → Mar 2033.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.